Brachytherapy is an invaluable tool in the radiation oncologist's toolbox, but the perceived proficiency among residents has been variable and there is great diversity in how programs deliver brachytherapy.
This educational series explores the evolving role of radiation therapy in managing nonmalignant conditions, addressing current challenges, emerging evidence, and specialized applications in clinical practice.
This activity is a case-based discussion on the role of radiation therapy in the treatment of cutaneous squamous cell carcinoma. We have three academic physicians representing three different geographic locations within the United States, from the east coast, west coast and sun belt region.
This activity is a case-based discussion on the role of radiation therapy in the treatment of cutaneous squamous cell carcinoma. We have three academic physicians representing three different geographic locations within the United States, from the east coast, west coast and sun belt region.
With technological advances re-irradiation has rapidly become common and an important part of cancer management to new or recurrent tumors, yet is clinically challenging given risks of serious toxicity from cumulative doses.
Radiopharmaceutical Therapy (RPT) is an emerging modality with significant potential to impact future oncological management across many disease settings.
Theranostics, a treatment paradigm pairing diagnostic molecular imaging with radiopharmaceutical therapy (RPT), is resurgent, mainly driven by the FDA approvals of 177Lu-dotatate for neuroendocrine tumors and 177Lu-PSMA-617 for prostate cancer.
Radiation dosimetry plays a critical role in the development and application of radiotherapeutic pharmaceuticals, ensuring both efficacy and safety in treatment.
Facebook
X
LinkedIn
Forward
